arrow_back Back to App

Access to Breast Cancer Diagnosis: No Cost-Sharing

This new bill aims to eliminate out-of-pocket costs like deductibles and co-pays for diagnostic and supplemental breast examinations. This means health insurance plans will be required to cover these tests fully, making early breast cancer detection more accessible and reducing financial burdens for patients. These changes will take effect from January 1, 2024.
Key points
No out-of-pocket costs for diagnostic and supplemental breast exams (mammography, MRI, ultrasound).
Health insurance plans must cover 100% of these test costs, without deductibles or co-pays.
Changes also apply to high-deductible health plans, allowing earlier tests without meeting the deductible.
The bill does not prohibit requiring prior authorization for tests, but it cannot involve additional costs.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_3851
Sponsor: Rep. Dingell, Debbie [D-MI-6]
Process start date: 2023-06-06
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Access to Breast Cancer Diagnosis Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_3851.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-06-06.

What are the main provisions?

Key points include:

  • No out-of-pocket costs for diagnostic and supplemental breast exams (mammography, MRI, ultrasound).
  • Health insurance plans must cover 100% of these test costs, without deductibles or co-pays.
  • Changes also apply to high-deductible health plans, allowing earlier tests without meeting the deductible.
  • The bill does not prohibit requiring prior authorization for tests, but it cannot involve additional costs.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Dingell, Debbie [D-MI-6].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health